These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3044079)

  • 21. Hepatitis B viral infection.
    Thomas HC
    Am J Med; 1988 Aug; 85(2A):135-40. PubMed ID: 3136648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
    J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
    Yang YF; Zhao W; Zhong YD; Xia HM; Shen L; Zhang N
    J Viral Hepat; 2009 Apr; 16(4):265-71. PubMed ID: 19220736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
    J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Virostatic treatment of chronic hepatitis].
    Schmid M
    Schweiz Med Wochenschr; 1990 Apr; 120(15):560-2. PubMed ID: 2336559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic hepatitis B with interferon: experience in Asian patients.
    Lok AS; Lai CL; Wu PC; Lau JY; Leung EK; Wong LS
    Semin Liver Dis; 1989 Nov; 9(4):249-53. PubMed ID: 2690348
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
    J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral therapy of the Asian patient with chronic hepatitis B.
    Lok AS
    Semin Liver Dis; 1993 Nov; 13(4):360-6. PubMed ID: 8303317
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
    Franco A; Barnaba V; Levrero M; Ruberti G; Van Dyke A; Bonavita MS; Balsano F
    J Hepatol; 1986; 3 Suppl 2():S239-43. PubMed ID: 3298412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience.
    Thomas HC; Scully LJ; McDonald JA
    J Hepatol; 1986; 3 Suppl 2():S193-7. PubMed ID: 3298407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the treatment of chronic hepatitis B with interferon alfa (wellferon)].
    Gładysz A; Mach G; Juszczyk J; Simon K; Machaj A; Halota W; Molin I; Zalewska M
    Przegl Epidemiol; 1991; 45(4):321-3. PubMed ID: 1841410
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
    La Banda F; Ruiz Moreno M; Carreño V; Bartolome J; Gutiez J; Ramon y Cajal S; Moreno A; Mora I; Carlos Porres J
    Lancet; 1988 Jan; 1(8579):250. PubMed ID: 2893078
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon as treatment for viral hepatitis: a progress report.
    Lee WM
    J S C Med Assoc; 1990 Aug; 86(8):440-4. PubMed ID: 2120512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune effects of alpha-interferon in chronic liver disease.
    Peters M; Walling DM; Waggoner J; Avigan MI; Sjogren M; Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S283-9. PubMed ID: 3598159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.
    McDonald EM; Mann AH; Thomas HC
    Lancet; 1987 Nov; 2(8569):1175-8. PubMed ID: 2890808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection.
    Hadziyannis SJ
    Hepatology; 1988; 8(3):696-8. PubMed ID: 3286465
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon and the liver].
    Poitrine A; Chousterman S; Chousterman M
    Gastroenterol Clin Biol; 1986; 10(8-9):589-603. PubMed ID: 2430851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.